KAWIN

Kawin is located in the Beijing Economy-Technology Development Area (BDA), a national development zone in Beijing. Throughout our corporate development before IPO, Kawin established strategic partnerships with Legend Capital, Haitong Capital, Cybernaut, Lilly Asia Ventures (LAV), and meanwhile won several domestic honors such as Zhongguancun Top 100 High-growth Enterprise, and Beijing G20 enterprises (G20 projects). On February 8, 2021, Kawin was listed on Shanghai Stock Exchange STAR Market... Founded in 2008, Beijing Kawin Technology Share-Holding Co., Ltd. ("Kawin"; stock code 688687) is a biopharmaceutical company focused on viral and immune diseases, and committed to offering treatment solutions based on our biotech technology platforms.